A new FDA-approved blood test for Alzheimer disease could transform diagnosis and treatment accessibility, according to this conversation with Howard Fillit, MD, and Anthony “Nino” Sireci, MD, MSc.
Howard Fillit, MD
Advertisement
Articles by Howard Fillit, MD
Advertisement
Latest Updated Articles
- Opportunities for Improving Managed Care for Individuals with Dementia: Part I - The Issues
Published: March 1st 1999 | Updated:
- Opportunities for Improving Managed Care for Individuals with Dementia: Part II - A Framework for Care
Published: March 1st 1999 | Updated:
- The Pharmacoeconomics of Alzheimer's Disease
Published: December 1st 2000 | Updated:
- Managed Care Decisions in Alzheimer's Disease
Published: December 1st 2000 | Updated:
- Use of Ineffective or Unsafe Medications Among Members of a Medicare HMO Compared to Individuals in a Medicare Fee-for-Service Program
Published: April 1st 1997 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
2
Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps
3
Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD
4
Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH
5